Chi Michael, chief operating officer at Hims & Hers Health (HIMS), has been a consistent seller of company stock over the past year, with Form 4 filings showing 68 total transactions and roughly $7.76 million in open-market sales. The most recent activity, dated June 17, 2026, shows a sale of approximately $441,850, following a March 17, 2026 disposition worth about $2.40 million and a December 17, 2025 sale of roughly $504,762. These sales are the only cash-generating trades in the record; Michael has not made a single open-market purchase, and his total acquired value from grants and exercises stands at zero.
The pattern is dominated by mechanical and compensatory events rather than discretionary buying. The June 2026 filing shows five option exercises (coded M) with no reported value, paired with a $1.44 million tax-withholding transaction (coded F) — an automatic share surrender that reduces his position without a market sale. Similarly, the March 2026 filing includes six exercises, a $971,330 tax withholding, and a separate $4.92 million withholding event, alongside the $2.40 million open-market sale. A February 2026 grant (coded A) also appears with no dollar value, indicating equity compensation rather than a purchase.
Across the trailing twelve months, Michael’s selling bias is unambiguous: three open-market sales totaling roughly $3.35 million, no buys, and a steady stream of option exercises and tax-related surrenders. The December 2025 through June 2026 window shows a quarterly rhythm — exercises on the 13th or 15th, followed by sales on the 17th — consistent with a scheduled vesting-and-disposition cycle. While the dollar amounts are material, the absence of any purchase activity and the reliance on automatic withholdings suggest a passive, programmatic approach to liquidity rather than a directional bet on HIMS shares.
AI-assisted summary